Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction in Refractory Meningiomas Treated by SSTR-targeted Peptide Receptor Radionuclide Therapy
Latest Information Update: 10 Jul 2023
At a glance
- Drugs Lutetium-(177Lu)-oxodotreotide (Primary)
- Indications Meningioma
- Focus Diagnostic use; Pharmacokinetics
Most Recent Events
- 05 Jul 2023 Status changed from not yet recruiting to completed.
- 15 Sep 2022 New trial record